Peluntamig
Peluntamig is an experimental bispecific antibody from Phanes Therapeutics in phase 2 trials for non-small-cell lung cancer and neuroendocrine tumours, aimed at CD47 and DLL3.
Overview
Peluntamig (PT217) is a bispecific antibody developed by Phanes Therapeutics. Its targets are CD47 and DLL3. ClinicalTrials.gov describes the intervention as: A bispecific antibody (bsAb) against DLL3 and CD47. It is the investigational product in 1 recruiting or active industry-led phase 2 and phase 3 interventional cancer trial, in non-small-cell lung cancer and neuroendocrine tumours. The largest, NCT05652686, plans to enrol 203 participants with primary completion expected 2027-12. Status reflects the highest phase registered on ClinicalTrials.gov at the 2026-09-11 check; no efficacy results are recorded here.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Latest papers
topQuery for this drug: (TITLE:"Peluntamig" OR ABSTRACT:"Peluntamig" OR TITLE:"PT217" OR ABSTRACT:"PT217" OR TITLE:"Peluntamig PT217" OR ABSTRACT:"Peluntamig PT217") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Peluntamig, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentDJI136
Shares DLL3, Non-small-cell lung cancer and the tags pipeline, ctgov-ingest.
- TreatmentZL-1310
Shares DLL3, Non-small-cell lung cancer and the tags pipeline, ctgov-ingest.
- TreatmentSpevatamig
Shares CD47 and the tags pipeline, ctgov-ingest.
- TreatmentZG006
Shares Neuroendocrine tumours, Non-small-cell lung cancer and the tags pipeline, ctgov-ingest.
- TreatmentVRN110755
Shares Non-small-cell lung cancer and the tags pipeline, ctgov-ingest.
- TreatmentSSGJ-706
Shares Non-small-cell lung cancer and the tags pipeline, ctgov-ingest.
- TreatmentBA3071
Shares Non-small-cell lung cancer and the tags pipeline, ctgov-ingest.
- TreatmentJS111
Shares Non-small-cell lung cancer and the tags pipeline, ctgov-ingest.